@article{03bf33f5433c4b83aebb554786757f9d,
title = "Tumor dormancy and disease recurrence",
keywords = "Cancer recurrence, Cellular senescence, Dormant tumor cells, Senolytics",
author = "Kirkland, {James L.}",
note = "Funding Information: The articles in this series all point to a need to support research focussed on the characteristics and consequences of senolytic-resistant TIS/dormant cancer cells. Indeed, directed funding and support from the National Cancer Institute, other NIH and governmental components, public and private foundations, and universities around the world is urgently needed. Acknowledgements Funding Information: JLK is supported by NIH grants R37AG 013925, R33AG 061456, R01AG 68048, R01AG 64165, and P01AG 062413, the Connor Fund, Robert J. and Theresa W. Ryan, the Noaber Foundation. Funding Information: Thanks to Larissa Langhi Prata, Ph.D., Mayo Clinic, for creating the figure accompanying this Commentary and to Tamara Tchkonia, Ph.D., Mayo Clinic, for advice and discussions about the topics covered.",
year = "2023",
month = mar,
doi = "10.1007/s10555-023-10096-0",
language = "English (US)",
volume = "42",
pages = "9--12",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "1",
}